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Recently, much attention had been directed toward the association of serum magnesium and vitamin D level in general population and renal 
failure patients. Recently Kelishadi et al. conducted a 
study to test the correlation of serum magnesium with 
serum vitamin D (25(OH)D) level in 330 students, aged 
range from 10 to 18 years (1). In this investigation, they 
observed the significant correlation of serum magnesium 
with 25(OH)D serum level. They recommended further 
investigations to find the underlying mechanisms and the 
clinical significance of the current findings (1). In a cross-
sectional study on 41 patients of end-stage kidney failure 
on maintenance hemodialysis, we observed a significant 
positive association of serum magnesium level with 25 OH 
vitamin D (r= 0.40, p= 0.009). This significant association 
was strongly positive in diabetic and nondiabetic 
patients, individually for both female and male groups 
(2). Likewise, Gandhe et al., carried out a study to test 
the probable correlation of vitamin D3, and magnesium 
level in type 2 diabetes mellitus (DM) individuals. They 
firstly found low magnesium levels in type 2 DM patients, 
as compared to healthy controls. Secondly, they found a 
positive correlation of vitamin D with magnesium level (r= 
0.92, p< 0.01). They interpreted that, vitamin D level can 
also influence the magnesium status. They additionally 
found the negative association of magnesium with insulin 
resistance (3). Thus, hypomagnesemia may leads to an 
increased insulin resistance and also established the fact 
that, low magnesium status influences glucose metabolism, 
too (3-7). Fibroblast growth factor-23 is associated with 
atherosclerosis and cardiovascular mortality in chronic 
renal failure patients and healthy individuals (8-11). It 
was found that, magnesium deficiency increases serum 
fibroblast growth factor 23(FGF23) level as well (12). 
Thus, the positive association of magnesium deficiency 
and FGF23 increase (1,12-17), further explain the 
significance of magnesium deficiency and vitamin D, 
 Implication for health policy/practice/research/
medical education
Association of serum magnesium with vitamin D is 
especially important in the pediatric group and implies 
to further pay attention to reach the micronutrients to 
the pediatric individuals, as a possible prevention of 
progression of kidney disease in this population. 
while vitamin D has a role in magnesium metabolism, 
too. Association of serum magnesium with vitamin D is 
especially important in the pediatric group that observed 
by Kelishadi et al., (1) and implies to further pay attention 
to reach the micronutrients to the pediatric individuals, as 
a possible prevention of progression of kidney disease in 
this population. 
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